Over the years, various sites of ventricular pacing have been evaluated in clinical trials. Earlier trials established the detrimental effects of right ventricular (RV) apical pacing, including increased risk of atrial fibrillation, heart failure (HF), and mortality. Alternate RV pacing sites have yielded mixed results.1 Biventricular (BiV) pacing in advanced HF and electrical dyssynchrony reduced HF hospitalizations and mortality. Recently, 2 trials evaluated the clinical utility of BiV pacing in the setting of heart block and demonstrated equivocal results.